207 related articles for article (PubMed ID: 17262808)
1. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.
Sepehri S; Kotlowski R; Bernstein CN; Krause DO
Inflamm Bowel Dis; 2007 Jun; 13(6):675-83. PubMed ID: 17262808
[TBL] [Abstract][Full Text] [Related]
2. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
Forbes JD; Van Domselaar G; Bernstein CN
Inflamm Bowel Dis; 2016 Apr; 22(4):817-25. PubMed ID: 26937623
[TBL] [Abstract][Full Text] [Related]
3. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.
Conte MP; Schippa S; Zamboni I; Penta M; Chiarini F; Seganti L; Osborn J; Falconieri P; Borrelli O; Cucchiara S
Gut; 2006 Dec; 55(12):1760-7. PubMed ID: 16648155
[TBL] [Abstract][Full Text] [Related]
4. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.
Kotlowski R; Bernstein CN; Sepehri S; Krause DO
Gut; 2007 May; 56(5):669-75. PubMed ID: 17028128
[TBL] [Abstract][Full Text] [Related]
6. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two fingerprinting techniques, terminal restriction fragment length polymorphism and automated ribosomal intergenic spacer analysis, for determination of bacterial diversity in aquatic environments.
Danovaro R; Luna GM; Dell'anno A; Pietrangeli B
Appl Environ Microbiol; 2006 Sep; 72(9):5982-9. PubMed ID: 16957219
[TBL] [Abstract][Full Text] [Related]
8. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.
Vasquez N; Mangin I; Lepage P; Seksik P; Duong JP; Blum S; Schiffrin E; Suau A; Allez M; Vernier G; Tréton X; Doré J; Marteau P; Pochart P
Inflamm Bowel Dis; 2007 Jun; 13(6):684-92. PubMed ID: 17206669
[TBL] [Abstract][Full Text] [Related]
9. [Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease].
Ran WB; Ouyang Q; Shi W
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2884-9. PubMed ID: 24373401
[TBL] [Abstract][Full Text] [Related]
10. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
[TBL] [Abstract][Full Text] [Related]
11. A new transcription factor that regulates TNF-alpha gene expression, LITAF, is increased in intestinal tissues from patients with CD and UC.
Stucchi A; Reed K; O'Brien M; Cerda S; Andrews C; Gower A; Bushell K; Amar S; Leeman S; Becker J
Inflamm Bowel Dis; 2006 Jul; 12(7):581-7. PubMed ID: 16804395
[TBL] [Abstract][Full Text] [Related]
12. Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA.
Hotte NS; Salim SY; Tso RH; Albert EJ; Bach P; Walker J; Dieleman LA; Fedorak RN; Madsen KL
PLoS One; 2012; 7(5):e37932. PubMed ID: 22649567
[TBL] [Abstract][Full Text] [Related]
13. Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.
Fyderek K; Strus M; Kowalska-Duplaga K; Gosiewski T; Wedrychowicz A; Jedynak-Wasowicz U; Sładek M; Pieczarkowski S; Adamski P; Kochan P; Heczko PB
World J Gastroenterol; 2009 Nov; 15(42):5287-94. PubMed ID: 19908336
[TBL] [Abstract][Full Text] [Related]
14. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
Zhang W; Teng G; Wu T; Tian Y; Wang H
Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
[TBL] [Abstract][Full Text] [Related]
15. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease.
Ricanek P; Lothe SM; Szpinda I; Jorde AT; Brackmann S; Perminow G; Jørgensen KK; Rydning A; Vatn MH; Tønjum T;
J Crohns Colitis; 2010 Nov; 4(5):561-6. PubMed ID: 21122560
[TBL] [Abstract][Full Text] [Related]
16. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
[TBL] [Abstract][Full Text] [Related]
17. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
[TBL] [Abstract][Full Text] [Related]
18. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
20. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
